title: [Atomoxetine in ADHD: caution].
authors.affiliation: Centre d'enseignement, de recherche et de traitement des addictions, hôpital Paul-Brousse 94800 Villejuif.
authors.forename: Laurent
authors.initials: L
authors.lastname: Karila
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000453:epidemiology / Q000628:therapy; D001521:Behavior Therapy; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D003071:Cognition / Q000187:drug effects; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use; D009043:Motor Activity / Q000187:drug effects; D011437:Propylamines / Q000009:adverse effects* / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012640:Seizures / Q000139:chemically induced / Q000453:epidemiology; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D018759:Adrenergic Uptake Inhibitors; D000697:Central Nervous System Stimulants; D011437:Propylamines; D008774:Methylphenidate; D000069445:Atomoxetine Hydrochloride